Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference
Yahoo Finance · Oct 29, 2026 · Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
SAN DIEGO, October 29, 2026--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that management is scheduled to present at the Stifel 2026 Healthcare Conference on Thursday, November 12th at 8:40 a.m. ET.
Not investment advice. Headline and summary only, not a full reprint.